122 related articles for article (PubMed ID: 6368605)
1. Increased serum IgE concentrations during infection and graft versus host disease after bone marrow transplantation.
Walker SA; Rogers TR; Perry D; Hobbs JR; Riches PG
J Clin Pathol; 1984 Apr; 37(4):460-2. PubMed ID: 6368605
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.
Saarinen UM; Strandjord SE; Warkentin PI; Cheung NK; Lazarus HM; Coccia PF
Transplantation; 1987 Oct; 44(4):540-6. PubMed ID: 3313843
[TBL] [Abstract][Full Text] [Related]
3. Serum IgE levels after bone marrow transplantation.
Abedi MR; Bäckman L; Persson U; Ringdén O
Bone Marrow Transplant; 1989 May; 4(3):255-60. PubMed ID: 2659111
[TBL] [Abstract][Full Text] [Related]
4. IgE allotypes in sera of mice with autoimmune diseases and in mice with graft-versus-host disease after transfusion or bone marrow transplantation.
Miyajima H; Abe K; Ushiyama C; Okumura K; Ovary Z; Hirano T
Int Arch Allergy Immunol; 1996 Oct; 111(2):152-5. PubMed ID: 8859223
[TBL] [Abstract][Full Text] [Related]
5. Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation.
Ringdén O; Persson U; Johansson SG; Wilczek H; Gahrton G; Groth CG; Lundgren G; Lönnqvist B; Möller E
Blood; 1983 Jun; 61(6):1190-5. PubMed ID: 6340757
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
7. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
8. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
[TBL] [Abstract][Full Text] [Related]
9. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
10. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.
Walker SA; Rogers TR; Riches PG; White S; Hobbs JR
J Clin Pathol; 1984 Sep; 37(9):1018-21. PubMed ID: 6381551
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
12. [Acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation].
Kai S; Shinohara Y; Ifuku H; Ohe Y; Misawa M; Noguchi K; Kohsaki M; Kanamaru A; Hara H; Nagai K
Rinsho Ketsueki; 1985 Jan; 26(1):20-7. PubMed ID: 3889401
[No Abstract] [Full Text] [Related]
13. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
14. Defective neutrophil chemotaxis in bone marrow transplant patients.
Clark RA; Johnson FL; Klebanoff SJ; Thomas ED
J Clin Invest; 1976 Jul; 58(1):22-31. PubMed ID: 777029
[TBL] [Abstract][Full Text] [Related]
15. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.
Tsoi MS; Dobbs S; Brkic S; Ramberg R; Thomas ED; Storb R
Transplantation; 1984 Jun; 37(6):556-61. PubMed ID: 6233768
[TBL] [Abstract][Full Text] [Related]
16. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
18. Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation.
Walker SA; Riches PG; Wild G; Ward AM; Shaw PJ; Desai S; Hobbs JR
Clin Exp Immunol; 1986 Dec; 66(3):633-9. PubMed ID: 2436842
[TBL] [Abstract][Full Text] [Related]
19. Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections.
Paulin T; Ringdén O; Nilsson B
Bone Marrow Transplant; 1987 Feb; 1(3):317-28. PubMed ID: 3332141
[TBL] [Abstract][Full Text] [Related]
20. Association of GSTO2 (N142D), GSTT1, and GSTM1 Polymorphisms With Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Khosravi M; Izaddoust M; Saadat I; Karimi MH; Ramzi M
Exp Clin Transplant; 2016 Aug; 14(4):436-40. PubMed ID: 26103006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
